1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Sham procedure control: new trials by email Literature Review of Sham procedure control trials Research Report on Sham procedure control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD BS01, Sham procedure control - Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) | Phase 1 / Phase 2 | Recruiting | Bionic Sight LLC | 40 | 2026-01-08 | 2026-01-23 |
| Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants Human Allogenic Umbilical Cord Mesenchymal Stromal Cells, Sham procedure control - Bronchopulmonary Dysplasia (BPD), ELGAN (22-28SA) | Phase 2 | Not yet recruiting | Ottawa Hospital Research Institute | 168 | 2025-10-01 | 2025-07-10 |
Bronchopulmonary Dysplasia (1) · Geographic Atrophy (1) · Premature Birth (1)
Bionic Sight LLC (1) · Ottawa Hospital Research Institute (1)
Canada (1) · United States (1)